Oncogenic mutations of KRAS modulate its turnover by the CUL3/LZTR1 E3 ligase complex. (2024)

First Author: Damianou A
Attributed to:  Substrate Peptidomimetic Inhibitors (SPIs) of the COP9 signalosome funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.26508/lsa.202302245

PubMed Identifier: 38453365

Publication URI: http://europepmc.org/abstract/MED/38453365

Type: Journal Article/Review

Volume: 7

Parent Publication: Life science alliance

Issue: 5

ISSN: 2575-1077